From a Shareholders' perspective NEU has performed remarkably poorly relative to the drug pipeline's ODD emphasis, advanced Phases, and cash on hand.
From a Sufferers', Parents', and Carers' perspective NEU is one of very few biotechs that have provided real hope, and I'm sure is the subject of a few prayers.
From My perspective I'm financially able to wait, and even to selectively nibble away small amounts.
Family for now... and forever!
OV
ABCDEFGHIJKMNOPQRSTUVWXYZ! (Nod to Hitchcock's Christmas Greeting.)
Rett Syndrome Study - new site, page-13
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.52 |
Change
0.660(3.32%) |
Mkt cap ! $2.622B | |||
| Open | High | Low | Value | Volume |
| $20.00 | $20.66 | $19.94 | $6.431M | 315.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1024 | $20.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.53 | 285 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |